<DOC>
	<DOCNO>NCT01239771</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacokinetics TC-5214 medically stable elderly subject follow multiple oral dos .</brief_summary>
	<brief_title>A Study Assess Safety Tolerability Well Absorption Excretion TC-5214 Medically Stable Elderly Subjects</brief_title>
	<detailed_description />
	<criteria>Medically stable male female subject age great equal 65 year suitable vein cannulation repeat venipuncture . Subjects may control chronic disease hypertension , type 2 diabetes , osteoarthritis , stable chronic obstructive pulmonary disease , mild moderate renal insufficiency ( Estimated glomerular filtration rate ( eGFR ) per Modified Diet Renal Disease [ MDRD ] formula &gt; 50 mL/min/1.73 m2 ) , rhinitis etc . long significant change medical condition medication precede 6 week . Classification renal impairment base use MDRD equation Male subject sexually active must use condom partner childbearing potential must use reliable method contraception first dose investigational product 3 month last dose Have body mass index ( BMI ) 19 32 kg/m2 weigh least 50 kg History clinically significant medical , neurologic psychiatric disease disorder ( previously define acceptable population , see inclusion criterion 1 ) , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study : This include seizure activity repeat episode major depression Significant cardiovascular cerebrovascular disease : history acute coronary syndrome ; angina symptomatic last 6 month ; significant symptomatic arrhythmia ; stroke ; transient ischemic attack occur last 6 month History presence gastrointestinal hepatic disease condition know interfere absorption , distribution , metabolism excretion drug Subjects type 2 diabetes must HbA1c le 8 % accord National Glycohemoglobin Standardization Program ( NGSP ) screen Significant renal insufficiency define eGFR per MDRD formula &lt; 50 mL/min/1.73 m2 ( individual eGFR measurement document protocol ) .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>stable disease</keyword>
	<keyword>oral</keyword>
	<keyword>tablet</keyword>
</DOC>